metodebok.no
Velg sykehus
NorCRIN
Siste 50 endringer
05.12.2025
Guidance safety report form - Appendix 10
05.12.2025
Clinical Investigation Report - Appendix 14
02.12.2025
First in Human Early Phase Clinical Trials - WI 1.10.c
27.11.2025
Roles and Responsibilites in Medical Device studies - SOP
27.11.2025
Statistics - SOP 1.2.b
26.11.2025
Roles and responsibilities in Clinical Trials - SOP
25.11.2025
Obtaining Informed Consent - SOP 1.3.b
25.11.2025
Monitoring for monitors - SOP 1.15.a
25.11.2025
Quality and Risk Management - SOP 1.10.a
25.11.2025
Investigational Medicinal Product (IMP) at Trial Start - SOP 1.8.a
24.11.2025
Clinical Investigations with Medical Device - SOP 2.1
24.11.2025
CIO Guidelines for Clinical Interventional and Observational Studies
24.11.2025
Training and Qualification – SOP 1.7.a
21.11.2025
Statistical Analysis Plan - Template
21.11.2025
Source Data List - Template
21.11.2025
IMP Accountability Form Common Stock Unnumbered - Template
21.11.2025
CTIS Statement on compliance Regulation (EU) 2016/679 - Template
21.11.2025
Participant ID-Log - Appendix 5
21.11.2025
Co-Monitoring - SOP 1.15.b
21.11.2025
Monitoring - SOP 1.14.a
21.11.2025
Agreements - SOP 1.13.a
21.11.2025
International Trials - WI 1.5.c
21.11.2025
EudraVigilance Registration and SUSAR Reporting - WI 1.4.c
21.11.2025
Definitions - SOP 1.1.b
17.11.2025
CTIS Compliance with applicable rules for biological samples - Template
07.11.2025
Application Process and Approvals - SOP 1.9.a
07.11.2025
CTIS Site Suitability - Template
07.11.2025
CTIS RFI Response List of Changes to the Application - template
04.11.2025
Safety Reporting - SOP 1.4.b
24.10.2025
Simplified Development Safety Update Report - Template
24.10.2025
Safety Planning - SOP 1.4.a
14.10.2025
Checklist Initiation of Clinical Trial - Sponsor - Template
14.10.2025
Sponsor Trial Oversight - SOP 1.5.a
13.10.2025
Preparing Written Information and Consent Form - SOP 1.3.a
13.10.2025
Transfer of Clinical Trial Tasks to other Hospitals (decentralised trials) - SOP 1.13.b
13.10.2025
Ongoing Trial Reports and Notifications - SOP 1.9.b
13.10.2025
Modifications after Trial Start – SOP 1.9.c
13.10.2025
Protocol - SOP 1.2.a
13.10.2025
Investigational Medicinal Product (IMP) Management at Clinical Trial Completion - SOP 1.8.c
13.10.2025
Investigational Medicinal Product (IMP) Management During Trial - SOP 1.8.b
13.10.2025
Individual Case Safety Report Form EudraVigilance - Template
13.10.2025
Data Management - SOP 1.12.b
13.10.2025
Advanced Therapies – SOP 1.11.a
06.10.2025
Study Files – SOP 1.6.a
06.10.2025
Trial Initiation Report - Template
06.10.2025
Monitoring Report - Template
03.10.2025
Training Log - Template
03.10.2025
Safety Information Review Log – Template
03.10.2025
Risk Assessment - Template
03.10.2025
Query List - Template
Error message
Info message
Ok message